Management of Cutaneous Head and Neck Squamous and Basal Cell Carcinomas for Immunocompromised Patients

By sjmartinez • July 15, 2023

Bommakanti KK, Kosaraju N, Tam K, Chai-Ho W, St John M. Management of Cutaneous Head and Neck Squamous and Basal Cell Carcinomas for Immunocompromised Patients. Cancers (Basel). 2023 Jun 26;15(13):3348. doi: 10.3390/cancers15133348. PMID: 37444461; PMCID: PMC10340306.

Tags: basal cell carcinoma, cutaneous squamous cell carcinoma, Hematology/Oncology, immunotherapy, non-melanoma skin cancer, Publications

Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer

O'Reilly EM, Wainberg ZA, Hendifar AE, Borad MJ, Pietrantonio F, Pant S, Hammel P, Cremolini C, Manji GA, Oberstein PE, Garrido-Laguna I, Springfeld C, Azad[...]

Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer

Wu YL, Hochmair M, Yang Y, Yang XN, Tsuboi M, Paz-Ares L, Yang JC, Wu L, Kim HR, Rieke DT, Johnson M, Besse B, Sharma[...]

A Phase Ib Study of Efmarodocokin Alfa, an Interleukin-22 Agonist, in Combination with Standard of Care, in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Arslan S, Cutler C, Alousi A, Hamadani M, Abhyankar SH, Pusic I, Ross M, Schiller G, Dash A, Liu W, Yu Y, Lekkerkerker A, Wong[...]